XML 21 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenues:        
Premiums and other considerations $ 15,841 $ 10,407 $ 43,649 $ 29,103
Annuity product charges 58,480 62,277 182,321 185,264
Net investment income 526,366 543,331 1,522,876 1,660,353
Change in fair value of derivatives (70,701) 205,011 826,484 (409,201)
Net realized gains (losses) on investments 4,933 (22,321) (2,764) (68,545)
Other revenue 7,644 0 7,644 0
Loss on extinguishment of debt 0 0 0 (2,024)
Total revenues 542,563 798,705 2,580,210 1,394,950
Benefits and expenses:        
Insurance policy benefits and change in future policy benefits 18,756 13,273 51,008 36,676
Interest sensitive and index product benefits 817,014 576,147 2,106,590 1,217,358
Amortization of deferred sales inducements (17,172) 416,983 93,283 415,396
Change in fair value of embedded derivatives (536,404) (1,732,497) (545,104) (1,855,623)
Interest expense on notes payable 6,535 6,388 19,322 19,161
Interest expense on subordinated debentures 1,342 1,323 3,994 4,232
Amortization of deferred policy acquisition costs (1,588) 622,596 185,329 623,409
Other operating costs and expenses 56,518 42,738 177,433 128,315
Total benefits and expenses 345,001 (53,049) 2,091,855 588,924
Income before income taxes 197,562 851,754 488,355 806,026
Income tax expense 44,697 184,554 107,500 143,308
Net income 152,865 667,200 380,855 662,718
Less: Preferred stock dividends 10,918 5,950 32,756 18,511
Net income available to common stockholders $ 141,947 $ 661,250 $ 348,099 $ 644,207
Earnings per common share $ 1.53 $ 7.20 $ 3.69 $ 7.02
Earnings per common share - assuming dilution $ 1.53 $ 7.17 $ 3.67 $ 7.00
Weighted average common shares outstanding: earnings per common share 92,478,154 91,861,167 94,325,984 91,769,932
Weighted average common shares outstanding: earnings per common share - assuming dilution 93,043,660 92,163,272 94,867,400 92,070,735